ZARS Initiates Phase 3 Clinical Trial of ThermoProfen

ZARS Initiates Phase 3 Clinical Trial of ThermoProfen: "SALT LAKE CITY, July 25 /PRNewswire/ -- ZARS, Inc., announced today that it commenced the first of two Phase 3 clinical trials of ThermoProfen(TM) in patients with mild to moderate osteoarthritis (OA) of the knee on June 26, 2007."